IN2014KN01664A - - Google Patents

Download PDF

Info

Publication number
IN2014KN01664A
IN2014KN01664A IN1664KON2014A IN2014KN01664A IN 2014KN01664 A IN2014KN01664 A IN 2014KN01664A IN 1664KON2014 A IN1664KON2014 A IN 1664KON2014A IN 2014KN01664 A IN2014KN01664 A IN 2014KN01664A
Authority
IN
India
Prior art keywords
pharmaceutical composition
combinations
properties
formulations
active ingredients
Prior art date
Application number
Other languages
English (en)
Inventor
Donna Walker Duggins
John Paul Mua
Darrell Eugene Holton Jr
Daniel Verdin Cantrell
Original Assignee
Niconovum Usa Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Niconovum Usa Inc filed Critical Niconovum Usa Inc
Publication of IN2014KN01664A publication Critical patent/IN2014KN01664A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IN1664KON2014 2012-02-10 2013-02-07 IN2014KN01664A (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13/370,505 US9763928B2 (en) 2012-02-10 2012-02-10 Multi-layer nicotine-containing pharmaceutical composition
PCT/US2013/025067 WO2013119760A1 (en) 2012-02-10 2013-02-07 Multi-layer nicotine-containing pharmaceutical composition

Publications (1)

Publication Number Publication Date
IN2014KN01664A true IN2014KN01664A (de) 2015-10-23

Family

ID=47722567

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1664KON2014 IN2014KN01664A (de) 2012-02-10 2013-02-07

Country Status (7)

Country Link
US (2) US9763928B2 (de)
EP (2) EP3735972A1 (de)
JP (4) JP6757879B2 (de)
CN (1) CN104203241A (de)
DK (1) DK2812000T3 (de)
IN (1) IN2014KN01664A (de)
WO (1) WO2013119760A1 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014134221A1 (en) * 2013-02-26 2014-09-04 Azhir Ari Compositions and methods for treatment in parkinson's disease patients
US10357054B2 (en) * 2013-10-16 2019-07-23 R.J. Reynolds Tobacco Company Smokeless tobacco pastille
US9375033B2 (en) * 2014-02-14 2016-06-28 R.J. Reynolds Tobacco Company Tobacco-containing gel composition
US9936720B2 (en) * 2014-05-15 2018-04-10 Purina Animal Nutrition Llc High fat poured feed block
US9968125B2 (en) 2015-01-09 2018-05-15 Philip Morris Products S.A. Nicotine—diketopiperazine microparticle formulations and methods of making the same
WO2016164470A1 (en) 2015-04-07 2016-10-13 Church & Dwight Co., Inc. Multicomponent gummy compositions with soft core
US11224594B2 (en) 2015-09-16 2022-01-18 Philip Morris Products S.A. Nicotine formulations and methods of making and using the same
US10149844B2 (en) 2015-09-16 2018-12-11 Philip Morris Products S.A. Inhalable nicotine formulations, and methods of making and using thereof
US20170071248A1 (en) 2015-09-16 2017-03-16 Sansa Corporation (Barbados) Inc. System and Method for Controlling the Harshness of Nicotine-Based Dry Powder Formulations
US9585835B1 (en) 2015-09-16 2017-03-07 Sansa Corporation (Barbados) Inc. Inhalable nicotine formulations and methods of making and using the same
EP4338735A3 (de) * 2015-11-25 2024-06-19 R. J. Reynolds Tobacco Company Nikotinsalze, cokristalle und cokristall-salzkomplexe
US10532046B2 (en) 2015-12-03 2020-01-14 Niconovum Usa, Inc. Multi-phase delivery compositions and products incorporating such compositions
US20170165252A1 (en) * 2015-12-10 2017-06-15 Niconovum Usa Inc. Protein-enriched therapeutic composition
US11612183B2 (en) * 2015-12-10 2023-03-28 R.J. Reynolds Tobacco Company Protein-enriched tobacco composition
US20170340000A1 (en) * 2016-05-31 2017-11-30 William Willard Drink container delivery system
IT201800004415A1 (it) * 2018-04-13 2019-10-13 Marcello Spadetto Prodotto di erboristeria per il divezzamento dalla nicotina e dal fumo di tabacco
CA3103734A1 (en) * 2018-07-13 2020-01-16 Mcneil Ab Chewing gum comprising nicotine
US11116720B2 (en) * 2018-08-29 2021-09-14 Nanthealth, Inc. Ice pop medicament delivery system and method
US11793230B2 (en) 2019-12-09 2023-10-24 Nicoventures Trading Limited Oral products with improved binding of active ingredients
US20210169129A1 (en) * 2019-12-09 2021-06-10 Nicoventures Trading Limited Lipid-containing oral composition
US20210169130A1 (en) * 2019-12-09 2021-06-10 Nicoventures Trading Limited Methods of manufacturing an oral composition
US11617744B2 (en) 2019-12-09 2023-04-04 Nico Ventures Trading Limited Moist oral compositions
US11883527B2 (en) 2019-12-09 2024-01-30 Nicoventures Trading Limited Oral composition and method of manufacture
US11889856B2 (en) 2019-12-09 2024-02-06 Nicoventures Trading Limited Oral foam composition
US11872231B2 (en) 2019-12-09 2024-01-16 Nicoventures Trading Limited Moist oral product comprising an active ingredient
US11826462B2 (en) 2019-12-09 2023-11-28 Nicoventures Trading Limited Oral product with sustained flavor release
US11969502B2 (en) 2019-12-09 2024-04-30 Nicoventures Trading Limited Oral products
US11672862B2 (en) * 2019-12-09 2023-06-13 Nicoventures Trading Limited Oral products with reduced irritation
CA3160750A1 (en) 2019-12-09 2021-06-17 Anthony Richard Gerardi Oral product comprising a cannabinoid
US11839602B2 (en) 2020-11-25 2023-12-12 Nicoventures Trading Limited Oral cannabinoid product with lipid component
US20220354785A1 (en) * 2021-04-22 2022-11-10 Nicoventures Trading Limited Oral lozenge products

Family Cites Families (177)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2033909A (en) 1934-12-19 1936-03-17 Niacet Chemicals Corp Manufacture of calcium levulinate
US3114642A (en) 1962-04-20 1963-12-17 Corn Products Co Hard candy and process for making same
US3438787A (en) 1967-03-09 1969-04-15 Atlas Chem Ind Sugarless confection
US3901248A (en) 1970-07-22 1975-08-26 Leo Ab Chewable smoking substitute composition
US3738845A (en) 1972-01-07 1973-06-12 Pfizer Process for the manufacture of sugarless confections
GB1489761A (en) 1974-03-08 1977-10-26 Amf Inc Process of treating tobacco
US4150677A (en) 1977-01-24 1979-04-24 Philip Morris Incorporated Treatment of tobacco
US4267847A (en) 1978-05-12 1981-05-19 British-American Tobacco Company Limited Tobacco additives
US4289147A (en) 1979-11-15 1981-09-15 Leaf Proteins, Inc. Process for obtaining deproteinized tobacco freed of nicotine and green pigment, for use as a smoking product
US4589428A (en) 1980-02-21 1986-05-20 Philip Morris Incorporated Tobacco treatment
DE3009031C2 (de) 1980-03-08 1983-04-21 B.A.T. Cigaretten-Fabriken Gmbh, 2000 Hamburg Verfahren zur Herstellung von Aromastoffen für Rauchprodukte
DE3009032C2 (de) 1980-03-08 1983-11-24 B.A.T. Cigaretten-Fabriken Gmbh, 2000 Hamburg Verfahren zur Herstellung von Aromastoffen für Rauchprodukte
IN158943B (de) 1981-12-07 1987-02-21 Mueller Adam
KR840000624A (ko) * 1982-06-02 1984-02-25 원본미기재 부식억제 페인트 조성물
US4452825A (en) 1982-09-01 1984-06-05 Nabisco Brands, Inc. Sorbitol-containing hard candy
GB8317576D0 (en) 1983-06-29 1983-08-03 Shaw A S W Consumer tobacco products
JPS6024172A (ja) 1983-07-21 1985-02-06 日本たばこ産業株式会社 たばこ用香料の製造方法
US4655231A (en) 1984-01-09 1987-04-07 Advanced Tobacco Products, Inc. Snuff and preparation thereof
US4716911A (en) 1986-04-08 1988-01-05 Genencor, Inc. Method for protein removal from tobacco
GB8615676D0 (en) 1986-06-26 1986-07-30 Stoppers Co Ltd Nicotine containing lozenge
US4727889A (en) 1986-12-22 1988-03-01 R. J. Reynolds Tobacco Company Tobacco processing
US5018540A (en) 1986-12-29 1991-05-28 Philip Morris Incorporated Process for removal of basic materials
US5005593A (en) 1988-01-27 1991-04-09 R. J. Reynolds Tobacco Company Process for providing tobacco extracts
US5435325A (en) 1988-04-21 1995-07-25 R. J. Reynolds Tobacco Company Process for providing tobacco extracts using a solvent in a supercritical state
US4887618A (en) 1988-05-19 1989-12-19 R. J. Reynolds Tobacco Company Tobacco processing
US5098730A (en) 1988-11-14 1992-03-24 Cultor Ltd. Dietetic sweetening composition
US4967771A (en) 1988-12-07 1990-11-06 R. J. Reynolds Tobacco Company Process for extracting tobacco
US4986286A (en) 1989-05-02 1991-01-22 R. J. Reynolds Tobacco Company Tobacco treatment process
US4941484A (en) 1989-05-30 1990-07-17 R. J. Reynolds Tobacco Company Tobacco processing
US5525351A (en) * 1989-11-07 1996-06-11 Dam; Anders Nicotine containing stimulant unit
US5121757A (en) 1989-12-18 1992-06-16 R. J. Reynolds Tobacco Company Tobacco treatment process
US5060669A (en) 1989-12-18 1991-10-29 R. J. Reynolds Tobacco Company Tobacco treatment process
US5512306A (en) 1992-06-19 1996-04-30 Pharmica Ab Smoking substitute
US5131414A (en) 1990-02-23 1992-07-21 R. J. Reynolds Tobacco Company Tobacco processing
US5065775A (en) 1990-02-23 1991-11-19 R. J. Reynolds Tobacco Company Tobacco processing
US5234008A (en) 1990-02-23 1993-08-10 R. J. Reynolds Tobacco Company Tobacco processing
US5099862A (en) 1990-04-05 1992-03-31 R. J. Reynolds Tobacco Company Tobacco extraction process
US5074319A (en) 1990-04-19 1991-12-24 R. J. Reynolds Tobacco Company Tobacco extraction process
US5089270A (en) * 1990-05-15 1992-02-18 L. Perrigo Company Capsule-shaped tablet
US5147654A (en) 1990-07-23 1992-09-15 Alza Corporation Oral osmotic device for delivering nicotine
US5110605A (en) 1990-08-21 1992-05-05 Oramed, Inc. Calcium polycarbophil-alginate controlled release composition and method
US5131415A (en) 1991-04-04 1992-07-21 R. J. Reynolds Tobacco Company Tobacco extraction process
US5197494A (en) 1991-06-04 1993-03-30 R.J. Reynolds Tobacco Company Tobacco extraction process
US5318050A (en) 1991-06-04 1994-06-07 R. J. Reynolds Tobacco Company Tobacco treatment process
FR2677524B1 (fr) 1991-06-14 1993-10-08 Roquette Freres Bonbon sucre cuit sans sucre et son procede de fabrication.
US5343879A (en) 1991-06-21 1994-09-06 R. J. Reynolds Tobacco Company Tobacco treatment process
DE69227773T2 (de) * 1991-07-03 1999-05-20 Pharmacia & Upjohn Co., Kalamazoo, Mich. Tabletten mit hohem gehalt an colestipolhydrochlorid
US5360022A (en) 1991-07-22 1994-11-01 R. J. Reynolds Tobacco Company Tobacco processing
US5148819A (en) 1991-08-15 1992-09-22 R. J. Reynolds Tobacco Company Process for extracting tobacco
US5230354A (en) 1991-09-03 1993-07-27 R. J. Reynolds Tobacco Company Tobacco processing
US5243999A (en) 1991-09-03 1993-09-14 R. J. Reynolds Tobacco Company Tobacco processing
US5301694A (en) 1991-11-12 1994-04-12 Philip Morris Incorporated Process for isolating plant extract fractions
US5445169A (en) 1992-08-17 1995-08-29 R. J. Reynolds Tobacco Company Process for providing a tobacco extract
US6602892B1 (en) 1993-06-10 2003-08-05 David P. L. Sachs Methods for nicotine replacement dosage determination
US5549906A (en) 1993-07-26 1996-08-27 Pharmacia Ab Nicotine lozenge and therapeutic method for smoking cessation
US5362496A (en) 1993-08-04 1994-11-08 Pharmetrix Corporation Method and therapeutic system for smoking cessation
SE9303574D0 (sv) 1993-11-01 1993-11-01 Kabi Pharmacia Ab Composition for drug delivery and method the manufacturing thereof
IT1274034B (it) 1994-07-26 1997-07-14 Applied Pharma Res Composizioni farmaceutiche a base di gomma da masticare e procedimento per la loro preparazione
US5723477A (en) 1994-11-10 1998-03-03 Sibia Neurosciences, Inc. Modulators of acetylcholine receptors
FR2728436A1 (fr) 1994-12-26 1996-06-28 Roquette Freres Sucre cuit et son procede de fabrication
US5604231A (en) 1995-01-06 1997-02-18 Smith; Carr J. Pharmaceutical compositions for prevention and treatment of ulcerative colitis
US5656284A (en) 1995-04-24 1997-08-12 Balkin; Michael S. Oral transmucosal delivery tablet and method of making it
US5583140A (en) 1995-05-17 1996-12-10 Bencherif; Merouane Pharmaceutical compositions for the treatment of central nervous system disorders
US5811126A (en) 1995-10-02 1998-09-22 Euro-Celtique, S.A. Controlled release matrix for pharmaceuticals
TR199802068T2 (xx) 1996-04-16 2000-01-21 Novartis Consumer Health S.A. H�zl� b�l�nen oral doz formu.
US6166048A (en) 1999-04-20 2000-12-26 Targacept, Inc. Pharmaceutical compositions for inhibition of cytokine production and secretion
JP3707798B2 (ja) 1996-05-13 2005-10-19 ノバルティス・コンシューマー・ヘルス・ソシエテ・アノニム 口内薬剤輸送系
GB9614902D0 (en) 1996-07-16 1996-09-04 Rhodes John Sustained release composition
DE19646392A1 (de) 1996-11-11 1998-05-14 Lohmann Therapie Syst Lts Zubereitung zur Anwendung in der Mundhöhle mit einer an der Schleimhaut haftklebenden, Pharmazeutika oder Kosmetika zur dosierten Abgabe enthaltenden Schicht
US5811442A (en) 1997-02-21 1998-09-22 Bencherif; Merouane Pharmaceutical compositions for the treatment of conditions associated with decreased blood flow
US6024981A (en) 1997-04-16 2000-02-15 Cima Labs Inc. Rapidly dissolving robust dosage form
US7214686B2 (en) 1997-06-30 2007-05-08 Targacept, Inc. Pharmaceutical compositions and methods for effecting dopamine release
US5840334A (en) 1997-08-20 1998-11-24 Fuisz Technologies Ltd. Self-binding shearform compositions
US5869098A (en) 1997-08-20 1999-02-09 Fuisz Technologies Ltd. Fast-dissolving comestible units formed under high-speed/high-pressure conditions
US20030176467A1 (en) 1997-09-25 2003-09-18 Sven Andersson Nicotine compositions
JPH11171769A (ja) * 1997-12-05 1999-06-29 Nichiko Pharmaceutical Co Ltd ３−イソブチリル−２−イソプロピルピラゾロ〔１，５−ａ〕ピリジンの徐放性製剤及びその製法
US6268386B1 (en) 1998-06-25 2001-07-31 Marshall Anlauf Thompson Nicotine beverage
US6298859B1 (en) 1998-07-08 2001-10-09 Novozymes A/S Use of a phenol oxidizing enzyme in the treatment of tobacco
US6358060B2 (en) 1998-09-03 2002-03-19 Jsr Llc Two-stage transmucosal medicine delivery system for symptom relief
US6596298B2 (en) 1998-09-25 2003-07-22 Warner-Lambert Company Fast dissolving orally comsumable films
SE9803986D0 (sv) 1998-11-23 1998-11-23 Pharmacia & Upjohn Ab New compositions
GB9826192D0 (en) 1998-12-01 1999-01-20 Controlled Theraputics Scotlan Oral transmucosal delivery
US7163705B2 (en) 1998-12-15 2007-01-16 Wm. Wrigley Jr. Company Coated chewing gum product and method of making
PT1061900E (pt) 1999-01-14 2005-04-29 Noven Pharma Composicoes e metodos para libertacao de uma droga
US6248363B1 (en) 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US6090401A (en) 1999-03-31 2000-07-18 Mcneil-Ppc, Inc. Stable foam composition
US7935362B2 (en) 1999-04-06 2011-05-03 Wm. Wrigley Jr. Company Over-coated product including consumable center and medicament
US6426090B1 (en) 1999-04-06 2002-07-30 Wm. Wrigley Jr. Company Over-coated product including tableted center and medicament
US6583160B2 (en) 1999-04-14 2003-06-24 Steve Smith Nicotine therapy method and oral carrier for assuaging tobacco-addiction
US20010016593A1 (en) 1999-04-14 2001-08-23 Wilhelmsen Paul C. Element giving rapid release of nicotine for transmucosal administration
US6248760B1 (en) 1999-04-14 2001-06-19 Paul C Wilhelmsen Tablet giving rapid release of nicotine for transmucosal administration
US6131584A (en) 1999-04-15 2000-10-17 Brown & Williamson Tobacco Corporation Tobacco treatment process
US6319510B1 (en) 1999-04-20 2001-11-20 Alayne Yates Gum pad for delivery of medication to mucosal tissues
DE19943496C1 (de) 1999-09-10 2001-05-17 Suedzucker Ag Direkt verpressbarer Rohstoff für Komprimate
DE19943491B4 (de) 1999-09-10 2010-04-01 Südzucker AG Mannheim/Ochsenfurt Verbesserte Komprimate
US6264981B1 (en) 1999-10-27 2001-07-24 Anesta Corporation Oral transmucosal drug dosage using solid solution
AU3221401A (en) 1999-11-30 2001-06-12 Rajesh Jain Fast dissolving composition with prolonged sweet taste
US6660754B1 (en) 2000-02-15 2003-12-09 Smithkline Beecham Corporation Method for reducing or eliminating smoking
US7115297B2 (en) 2000-02-22 2006-10-03 Suzanne Jaffe Stillman Nutritionally fortified liquid composition with added value delivery systems/elements/additives
US7067116B1 (en) 2000-03-23 2006-06-27 Warner-Lambert Company Llc Fast dissolving orally consumable solid film containing a taste masking agent and pharmaceutically active agent at weight ratio of 1:3 to 3:1
FR2823974B1 (fr) 2001-04-25 2004-10-15 Pf Medicament Pastille medicamenteuse a liberation lente du principe actif
US6872405B2 (en) 2001-05-10 2005-03-29 Yamanouchi Pharmaceutical Co., Ltd. Quick-disintegrating tablet in buccal cavity and manufacturing method thereof
US20030044458A1 (en) * 2001-08-06 2003-03-06 Curtis Wright Oral dosage form comprising a therapeutic agent and an adverse-effect agent
US6585997B2 (en) 2001-08-16 2003-07-01 Access Pharmaceuticals, Inc. Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds
US20040037879A1 (en) * 2001-11-02 2004-02-26 Adusumilli Prasad S. Oral controlled release forms useful for reducing or preventing nicotine cravings
KR20040062666A (ko) 2001-12-10 2004-07-07 조셉 로버트 나이트 니코틴 처리 음료
NZ534340A (en) 2002-02-07 2006-04-28 Pharmacia Corp Pharmaceutical dosage form for mucosal delivery
MXPA04007083A (es) 2002-02-20 2004-10-29 Upjohn Co Compuestos azabiciclicos para el tratamiento de enfermedades.
US7105173B1 (en) 2002-03-21 2006-09-12 Rolling Kenneth J Nicotine replacement applique
US20040101543A1 (en) 2002-03-22 2004-05-27 John Liu Nicotine-containing oral dosage form
US20030215553A1 (en) 2002-05-16 2003-11-20 Guillaume Ribadeau-Dumas Method for preparing non wrapped hard candies based on maltitol syrup
US6586449B1 (en) 2002-05-28 2003-07-01 Cambrex Charles City, Inc. Nicotine-containing, controlled release composition and method
ITMI20021392A1 (it) 2002-06-25 2003-12-29 Nicox Sa Forme farmaceutiche per la somministrazione orale di farmaci liquidi a temperatura ambiente dotate di migliore biodisponibilita'
US8216609B2 (en) 2002-08-05 2012-07-10 Torrent Pharmaceuticals Limited Modified release composition of highly soluble drugs
US7135484B2 (en) 2002-08-14 2006-11-14 Abbott Laboratories Azabicyclic compounds are central nervous system active agents
US6772767B2 (en) 2002-09-09 2004-08-10 Brown & Williamson Tobacco Corporation Process for reducing nitrogen containing compounds and lignin in tobacco
US20040052851A1 (en) 2002-09-16 2004-03-18 Graff Allan H. Modified release oral dosage form
GB0225351D0 (en) 2002-10-31 2002-12-11 Nestle Sa Confectionery product
JP4708795B2 (ja) * 2002-12-20 2011-06-22 ニコノヴァム エービー 物理的および化学的に安定なニコチン−含有粒状物質
US20040253307A1 (en) 2003-02-04 2004-12-16 Brian Hague Sugar-free oral transmucosal solid dosage forms and uses thereof
AU2004259006B2 (en) 2003-07-24 2010-10-07 Glaxosmithkline Llc Orally dissolving films
GB0320854D0 (en) * 2003-09-05 2003-10-08 Arrow No 7 Ltd Buccal drug delivery
ATE422355T1 (de) 2003-09-08 2009-02-15 Mcneil Ab Nikotinformulierungen und ihre verwendung
US20050123502A1 (en) 2003-10-07 2005-06-09 Chan Shing Y. Nicotine containing oral compositions
US8627828B2 (en) 2003-11-07 2014-01-14 U.S. Smokeless Tobacco Company Llc Tobacco compositions
EP1696923B1 (de) 2003-12-02 2009-08-19 Fertin Pharma A/S Nikotin-abgabeprodukt und herstellungsverfahren
US7337782B2 (en) 2004-08-18 2008-03-04 R.J. Reynolds Tobacco Company Process to remove protein and other biomolecules from tobacco extract or slurry
US20080014302A1 (en) * 2004-08-25 2008-01-17 Cadbury Adams Usa Llc Multi-region chewing gum composition including isomalt gum region
CA2589489C (en) 2004-11-30 2014-04-22 Fertin Pharma A/S Method of providing fast relief to a user of a nicotine chewing gum
AU2006226509A1 (en) 2005-03-22 2006-09-28 Niconovum Ab Use of an artificial sweetener to enhance absorption of nicotine
GB0508306D0 (en) 2005-04-25 2005-06-01 Bioprogress Technology Ltd Nicotine dosage forms
DK1890698T3 (da) 2005-06-01 2010-03-29 Fertin Pharma As Fremgangsmåde til fremstilling af et nikotinafgivelses-produkt
CA2646942C (en) 2006-03-16 2014-07-29 Niconovum Ab Improved snuff composition
JP2009529343A (ja) 2006-03-16 2009-08-20 ニコノヴァム エービー ニコチンの迅速放出を提供するチューインガム組成物
US20070269492A1 (en) 2006-05-16 2007-11-22 Per Steen New product and use and manufacture thereof
US20070269386A1 (en) * 2006-05-16 2007-11-22 Per Steen New product and use and manufacture thereof
US8642016B2 (en) 2006-07-21 2014-02-04 Jsrnti, Llc Medicinal delivery system, and related methods
US20080063748A1 (en) * 2006-09-08 2008-03-13 Cadbury Adams Usa Llc. Center-fill confectionery and chewing gum compositions containing suspended saccharide particles
WO2008040371A1 (de) 2006-09-29 2008-04-10 Nokia Siemens Networks Gmbh & Co. Kg Interaktiver dienst in einem telekommunikationsnetz
JP5784878B2 (ja) 2007-03-07 2015-09-24 ノバルティス アーゲー 経口投与可能なフィルム
US20080286340A1 (en) * 2007-05-16 2008-11-20 Sven-Borje Andersson Buffered nicotine containing products
US20080286341A1 (en) * 2007-05-16 2008-11-20 Sven-Borje Andersson Buffered coated nicotine containing products
US20080292683A1 (en) 2007-05-24 2008-11-27 Monosolrx, Llc. Film shreds and delivery system incorporating same
US8356606B2 (en) 2007-06-01 2013-01-22 Philip Morris Usa Inc. Production of micronized encapsulated tobacco particles for tobacco flavor delivery from an oral pouch
US20090004248A1 (en) 2007-06-29 2009-01-01 Frank Bunick Dual portion dosage lozenge form
EP2170093A1 (de) * 2007-07-27 2010-04-07 Cadbury Adams USA LLC Mehrteilige kaugummizusammensetzung mit gesättigten polyolen in partikelform
US20100260690A1 (en) 2007-09-18 2010-10-14 Arne Kristensen Stable chewing gum compositions comprising maltitol and providing rapid release of nicotine
US8336557B2 (en) 2007-11-28 2012-12-25 Philip Morris Usa Inc. Smokeless compressed tobacco product for oral consumption
WO2009080022A1 (en) * 2007-12-20 2009-07-02 Fertin Pharma A/S Compressed chewing gum tablet
US20090202635A1 (en) * 2008-02-08 2009-08-13 Stephen Michael Scott Delivery System, Application, and Method
TWI519322B (zh) * 2008-04-15 2016-02-01 愛戴爾製藥股份有限公司 包含弱鹼性藥物及控制釋放劑型之組合物
AR071420A1 (es) 2008-05-01 2010-06-16 Smithkline Beecham Corp Composicion de pastilla para chupar oral que comprende un principio activo de nicotina y procedimiento para fabricarla
CA2709774C (en) 2008-05-22 2012-10-02 Teva Pharmaceutical Industries Ltd. Varenicline tosylate, an intermediate in the preparation process of varenicline l-tartrate
WO2010044736A1 (en) 2008-10-14 2010-04-22 Mcneil Ab Multi portion intra-oral dosage form and use thereof
US20100124560A1 (en) * 2008-11-14 2010-05-20 Mcneil Ab Multi portion intra-oral dosage form and use thereof
US9155772B2 (en) 2008-12-08 2015-10-13 Philip Morris Usa Inc. Soft, chewable and orally dissolvable and/or disintegrable products
MX2011007399A (es) * 2009-01-09 2011-11-18 Panacea Biotec Ltd Suspension farmaceutica de liberacion doble.
EP2233134A1 (de) 2009-03-27 2010-09-29 McNeil AB Mehrteilige intraorale Darreichungsform mit organoleptischen Eigenschaften
US20100247586A1 (en) * 2009-03-27 2010-09-30 Andreas Hugerth Multi-Portion Intra-Oral Dosage Form With Organoleptic Properties
KR101138851B1 (ko) 2009-04-27 2012-05-09 김만규 금연 껌 조성물 및 그를 이용한 금연 껌 제조방법
EP2429321A4 (de) 2009-05-11 2013-03-06 Us Smokeless Tobacco Co Verfahren und vorrichtung zur aromatisierung von rauchlosem tabak
US8434496B2 (en) 2009-06-02 2013-05-07 R. J. Reynolds Tobacco Company Thermal treatment process for tobacco materials
US20110318411A1 (en) * 2010-06-24 2011-12-29 Luber Joseph R Multi-layered orally disintegrating tablet and the manufacture thereof
US20110220130A1 (en) 2009-12-15 2011-09-15 John-Paul Mua Tobacco Product And Method For Manufacture
US20110139164A1 (en) 2009-12-15 2011-06-16 R. J. Reynolds Tobacco Company Tobacco Product And Method For Manufacture
PL2515668T3 (pl) * 2009-12-21 2019-08-30 Intercontinental Great Brands Llc Powlekane wielostrefowe wyroby cukiernicze i sposoby ich wytwarzania
MX2012009586A (es) 2010-02-18 2012-09-12 Jatin Vasant Thakkar Patillas de gelatina blanda con nicotina.
US20110268809A1 (en) 2010-04-28 2011-11-03 Paul Andrew Brinkley Nicotine-Containing Pharmaceutical Compositions
US20110274628A1 (en) 2010-05-07 2011-11-10 Borschke August J Nicotine-containing pharmaceutical compositions
US9155321B2 (en) 2010-08-11 2015-10-13 R.J. Reynolds Tobacco Company Meltable smokeless tobacco composition
UA112974C2 (uk) 2010-09-16 2016-11-25 Джеі. Бі. Кемікалс Енд Фармасьютікалс Лімітид Нікотиновмісна композиція (варіанти)
US9775376B2 (en) 2010-12-01 2017-10-03 R.J. Reynolds Tobacco Company Smokeless tobacco pastille and moulding process for forming smokeless tobacco products
US9204667B2 (en) 2010-12-01 2015-12-08 R.J. Reynolds Tobacco Company Smokeless tobacco pastille and injection molding process for forming smokeless tobacco products
US20130078307A1 (en) * 2011-09-22 2013-03-28 Niconovum Usa, Inc. Nicotine-containing pharmaceutical composition
US9084439B2 (en) 2011-09-22 2015-07-21 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US9907748B2 (en) * 2011-10-21 2018-03-06 Niconovum Usa, Inc. Excipients for nicotine-containing therapeutic compositions
US9044035B2 (en) * 2012-04-17 2015-06-02 R.J. Reynolds Tobacco Company Remelted ingestible products

Also Published As

Publication number Publication date
US20170360767A1 (en) 2017-12-21
US9763928B2 (en) 2017-09-19
JP2015506979A (ja) 2015-03-05
JP2021054828A (ja) 2021-04-08
JP2019089785A (ja) 2019-06-13
US20130209540A1 (en) 2013-08-15
JP6757879B2 (ja) 2020-09-23
WO2013119760A1 (en) 2013-08-15
EP2812000A1 (de) 2014-12-17
EP3735972A1 (de) 2020-11-11
EP2812000B1 (de) 2020-05-06
JP2023061939A (ja) 2023-05-02
CN104203241A (zh) 2014-12-10
DK2812000T3 (da) 2020-07-06

Similar Documents

Publication Publication Date Title
IN2014KN01664A (de)
IN2014KN01663A (de)
IL222268A (en) Preserved pyrollo-pyridines, containing pharmaceutical preparations, combined preparations containing them and their use in the preparation of medicines
EP2568954A4 (de) Duftstoffformulierungen, verfahren zu ihrer herstellung und artikel damit
WO2013177419A3 (en) Lipid nanoparticle compositions and methods of making and methods of using the same
MX2020000984A (es) Una composicion farmaceutica que comprende nanoparticulas hibridas amorfas estables, de al menos un inhibidor de proteina quinasa y al menos un componente estabilizador polimerico y formador de matriz.
TN2012000611A1 (en) Formulations of rifaximin and uses thereof
PL2768937T3 (pl) Preparaty, ich zastosowanie jako środków do mycia naczyń lub do wytwarzania środków do mycia naczyń i ich wytwarzanie
HK1198921A1 (en) Antimicrobial compositions comprising dgla, 15-ohepa and/or 15-hetre and methods of use thereof dgla15-ohepa / 15-hetre
MX2013001677A (es) Formulaciones estables de linaclotida.
PL2768936T3 (pl) Preparaty, ich zastosowanie jako środków do zmywania naczyń lub do wytwarzania środków do zmywania naczyń i ich wytwarzanie
EP3878445A3 (de) Acamprosat-formulierungen, verfahren zur verwendung davon und kombinationen damit
MY161595A (en) Oral care compositions
MX346891B (es) Formulaciones en espuma que incluyen poliesteres de silicona.
HK1182934A1 (zh) 種抗疲勞的組合物及其製劑和應用
IL233825A (en) H1-indazole-3-carboxamide compounds, preparations containing them and their use in the preparation of medicines
PL2841549T3 (pl) Preparaty, ich zastosowanie jako środków do zmywania naczyń lub do wytwarzania środków do zmywania naczyń i ich wytwarzanie
PL2841548T3 (pl) Preparaty, ich zastosowanie jako środków do zmywania naczyń lub do wytwarzania środków do zmywania naczyń i ich wytwarzanie
MY165075A (en) Pharmaceutical composition comprising fimasartan and hydrochlorothiazide
GEP201706739B (en) Compositions comprising vortioxetine and donepezil
EP2898905A4 (de) Pelletförmige zusammensetzung zur medizinischen verwendung und formkörper
HK1208188A1 (en) Formulations for the delivery of active ingredients
MX371209B (es) Una composicion farmaceutica que comprende nanoparticulas hibridas amorfas estables, de al menos un inhibidor de proteina quinasa y al menos un componente estabilizador polimerico y formador de matriz.
MX2014015199A (es) Formulacion de pexiganan estable.
MX2014006574A (es) Formulaciones de acamprosato, metodos de uso de las mismas, y combinaciones que comprenden las mismas.